KATO; Atsuhiko

Patent Applications and Registrations

Patent applications and USPTO patent grants for KATO; Atsuhiko.The latest application filed is for "composition for prophylaxis or treatment of il-8 related diseases".

Company Profile

4.13.19

KATO; Atsuhiko - Shizuoka JP
Kato; Atsuhiko - Tokyo JP
Kato; Atsuhiko - Gotenba JP
Kato, Atsuhiko - Gotenba-shi JP
Kato; Atsuhiko - Isehara JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Composition For Prophylaxis Or Treatment Of Il-8 Related Diseases App 20210301011 - KAKIUCHI; Ayako ; et al.	2021-09-30
Cancer stem cell population and method for production thereof Grant 11,124,773 - Yamazaki , et al. September 21, 2	2021-09-21
Method for treating IL-8-related diseases Grant 11,053,308 - Kakiuchi , et al. July 6, 2	2021-07-06
Cancer stem cell-specific molecule Grant 10,934,351 - Yamazaki , et al. March 2, 2	2021-03-02
Cancer Stem Cell Population And Method For Production Thereof App 20200385686 - Yamazaki; Tatsumi ; et al.	2020-12-10
Cancer Stem Cell-specific Molecule App 20200325222 - Yamazaki; Tatsumi ; et al.	2020-10-15
Composition For Prophylaxis Or Treatment Of Il-8 Related Diseases App 20190169286 - KAKIUCHI; Ayako ; et al.	2019-06-06
Cancer stem cell isolation Grant 10,018,630 - Yamazaki , et al. July 10, 2	2018-07-10
Humanized Anti-Epiregulin Antibody, and Cancer Therapeutic Agent Comprising Said Antibody as Active Ingredient App 20170129950 - SHIRAIWA; Hirotake ; et al.	2017-05-11
Humanized anti-epiregulin antibody, and cancer therapeutic agent comprising said antibody as active ingredient Grant 9,556,264 - Shiraiwa , et al. January 31, 2	2017-01-31
Therapeutic Agent Comprising Humanized Anti-Epiregulin Antibody as Active Ingredient for Non-Small-Cell Lung Carcinoma Excluding Adenocarcinoma App 20160159919 - SUZUKI; Masami ; et al.	2016-06-09
Cancer Stem Cell-specific Molecule App 20160159904 - Yamazaki; Tatsumi ; et al.	2016-06-09
Humanized Anti-Epiregulin Antibody, and Cancer Therapeutic Agent Comprising Said Antibody as Active Ingredient App 20150110793 - Shiraiwa; Hirotake ; et al.	2015-04-23
Cancer Stem Cell Isolation App 20140314675 - Yamazaki; Tatsumi ; et al.	2014-10-23
Cancer Stem Cell-specific Molecule App 20140302511 - Yamazaki; Tatsumi ; et al.	2014-10-09
Method for detection of liver cancer cell using anti-glypican-3 antibody Grant 8,663,929 - Kataoka , et al. March 4, 2	2014-03-04
Cancer Stem Cell Mass And Process For Production Thereof App 20130288248 - Yamazaki; Tatsumi ; et al.	2013-10-31
Method For Searching And Screening For Target Of Anti-cancer Agent Using Non-human Animal Model Having Nog Established Cancer Cell Line Transplanted Therein App 20130019327 - Suzuki; Masami ; et al.	2013-01-17
Method For Detection Of Liver Cancer Cell Using Anti-glypican-3 Antibody App 20110091907 - Kataoka; Hiroaki ; et al.	2011-04-21
Method and system for optimizing alignment performance in a fleet of exposure tools Grant 7,679,069 - Adel , et al. March 16, 2	2010-03-16
Method And System For Optimizing Alignment Performance In A Fleet Of Exposure Tools App 20080073589 - Adel; Michael E. ; et al.	2008-03-27
Therapeutic Agent And Diagnostic Agent For Cholangiocarcinoma App 20080008710 - Aburatani; Hiroyuki ; et al.	2008-01-10
Chondrogenesis promoters and indolin-2-one derivatives Grant 6,716,628 - Kitamura , et al. April 6, 2	2004-04-06
Chondrogenesis promoters and indolin-2-one derivatives App 20030119896 - Kitamura, Hidetomo ; et al.	2003-06-26
Remedies and preventives for dental diseases App 20030049211 - Kato, Atsuhiko ; et al.	2003-03-13
Apparatus for guiding movement of an unmanned moving body Grant 4,924,153 - Toru , et al. May 8, 1	1990-05-08
Apparatus for guiding movement of an unmanned moving body Grant 4,862,047 - Suzuki , et al. August 29, 1	1989-08-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.